SCHEMBL8104635

SCHEMBL8104635

CC(C)OC(=O)CCCCC(S)CCS

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
ALDH1A1 P00352 3/20 0.39
GAA P10253 1/20 0.39
EPHX2 P34913 1/20 0.36
MAPT P10636 4/20 0.35
MAPK1 P28482 1/20 0.35
PGR P06401 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADRA2C P18825 1/20 0.33
SLC6A2 P23975 1/20 0.33
HTR2B P41595 1/20 0.33
MC3R P41968 1/20 0.33
SLC6A3 Q01959 1/20 0.33
PDE4D Q08499 1/20 0.33
SCN5A Q14524 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2581367 0.87 LMNA (0.39) LMNAALDH1A1MAPTMAPK1
SCHEMBL5829763 0.86 LMNA (0.73) LMNAALDH1A1MAPTMAPK1PGR
SCHEMBL7778506 0.82 TSHR (0.50) LMNAALDH1A1HSD17B10TSHR
SCHEMBL6741044 0.81 LMNA (0.64) LMNAALDH1A1GAAEPHX2MAPT
SCHEMBL7793705 0.80 LMNA (0.54) LMNAALDH1A1GAAEPHX2MAPT
SCHEMBL2580673 0.79 CYP1A2 (0.47) ALDH1A1GAAMAPTPGRADORA3
SCHEMBL304069 0.79 LMNA (0.61) LMNAALDH1A1GAAEPHX2MAPT
SCHEMBL15391 0.79 LMNA (0.78) LMNAALDH1A1GAAEPHX2MAPT
SCHEMBL8104259 0.79 LMNA (0.78) LMNAALDH1A1GAAEPHX2MAPT
SCHEMBL13558629 0.79 ALDH1A1 (0.48) LMNAALDH1A1PRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117902-A 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors GALDERMAN RESEARCH & DEVELOPMENT, S.N.C. SOPHIA ABTIPOLIS (FR) 2000-09-12 US disclosed